Abstract
This chapter is an update of the excellent one written by Jennekens and Jennekens-Schinkel in the previous edition of this textbook. Although there has been no breakthrough in the understanding of the neurological problems occurring in dialysis patients, the management of neurological patients has changed during the past few years, making it necessary to revise this chapter. Neurological complications in dialysis patients are common and diverse. Some relate to persistence of mild uraemia others complicate the dialysis procedure. A number of neurological disorders occur with relatively high frequency in patients requiring this form of therapy but do not relate to uraemia nor to the methods used for treatment
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Raskin NH, Fishman RA: Neurological disorders in renal failure (first of two parts). N Engl J Med 294: 143, 1976
Leavitt S, Tyler HR: Studies in asterixis. Arch Neurol 10: 370, 1964
Shahani BT, Young RR: Asterixis — a disorder of the neural mechanisms underlying sustained muscle contraction. in The Motor System: Neurophysiology and Muscle Mechanisms, edited by Shahani M, Amsterdam, Elsevier Scientific Publishing Company, 1976, p 301
Young RR, Shahani BT: Unilateral asterixis produced by a discrete CNS lesion. Trans Am Neurol Assoc 101: 306, 1976
Ericson G, Warren SE, Gribik M: Unilateral asterixis in a dialysis patient. JAMA 240: 671, 1978
Degos JD, Verroust J, Bochareine A, Serdaru M, Barbizet J: Asterixis in focal brain lesions. Arch Neurol 36: 705, 1979
Donat JR: Unilateral asterixis due to thalamic haemorrhage. Neurology 30: 83, 1980
Kudo Y, Fukai M, Yamadori A: Asterixis due to pontine haemorrhage. J Neurol Neurosurg Psychiatry 48: 487, 1985
Chadwick D, French AT: Uraemic myoclonus: an example of reticular reflex myoclonus. J Neurol Neurosurg Psychiatry 12: 52, 1979
Steinman TI, Yager HM: Catatonia in uremia. Ann Intern Med 89: 74, 1978
Madonick MJ, Berke K, Schiffer I: Pleocytosis and meningeal signs in uremia: report on 62 cases. Arch Neurol Psychiat 64: 431, 1950
Schreiner GE, Maher JF: Uremia. Biochemistry Pathogenesis and Treatment. Springfield IL, Charles C Thomas, 1961, p 256
Tyler HR: Neurologic disorders in renal failure. Am J Med 44: 734, 1968
Jennekens FGI, Dorhout Mees EJ, Van der Most van Spijk D: Clinical aspects of uraemic polyneuropathy. Nephron 8: 414, 1971
Jacob JC, Gloor P, Elwan H: Electroencephalographic changes in chronic renal failure. Neurology 15: 419, 1965
Luyten JAFM, Storm van Leeuwen W, Jennekens FGI: EEG in uraemic patients with neuropathy. Electroencephalogr Clin Neurophysiol 28: 423, 190
Cohen SN, Syndulko K, Rever B, Krant J, Coburn I, Tourtelotte WW: Visual evoked potentials and long latency event-related potentials in chronic renal failure. Neurology 33: 1219, 1983
Komsuoglu SS, Mehta R, Jones LA, Harding GFA: Brainstem auditory evoked potentials in chronic renal failure and maintenance hemodialysis. Neurology 35: 419, 1985
Brown JJ, Sufit RL, Sollinger HW: Visual evoked potential changes following renal transplantation. Electroencephalogr Clin Neurophysiol 66: 101, 1987
Olsen S: The brain in uraemia. Acta Psychiatr Scand 36(Suppl 156): 1, 1961
Kiley J, Hines O: Electroencephalographic evaluation of uremia, wave frequency evaluation on 40 uremic patients. Arch Intern Med 116: 67, 1965
Kiley JE, Woodruff MW, Pratt KL: Evaluation of encephalopathy by EEG frequcncy analysis in chronic dialysis patients. Clin Nephrol 5: 245, 1976
Heyman A, Patterson JL Jr, Jones RW Jr: Cerebral circulation and metabolism in uremia. Circulation 3: 558, 1951
Scheinberg P: Effects of uremia on cerebral blood flow and metabolism. Neurology 1: 101, 1954
Biasioli S, D’Andrea G, Feriani M, Chiarmante S, Fabris A, Ronco C, La Greca G: Uremic encephalopathy: an updating. Clin Nephrol 25: 57, 1986
Minkoff L, Gaertner G, Darab M, Levin ML: Inhibition of brain sodium-potassium ATPase in uremic rats. J Lab Clin Med 80: 71, 1972
Fraser CL, Sarnacki P, Arieff AI: Abnormal sodium transport in synaptosomes from brain of uremic rats. J Clin Invest 75: 2014, 1985
Hicks AM, Young DS, Wootton IDP: The effects of uraemic blood constituents on certain cerebral enzymes. Clin Chim Acta 9: 228, 1964
Bergström J: Uremia is an intoxication. Kidney Int 28(Suppl 17): S2, 1985
Massry SG: Neurotoxicity of parathyroid hormone in uremia. Kidney Int 28(Suppl 17): S5, 1985
Cooper JD, Lasarowitz VC, Arieff AI: Neurodiagnostic abnormalities in patients with acute renal failure. Evidence for neurotoxicity of parathyroid hormone. J Clin Invest 61: 1448, 1978
Fraser CL, Sarnacki P, Arieff A: Calcium transport abnormalities in uremic rat brain synaptosomes. J Clin Invest 76: 1789, 1985
Alfrey AC, Mishell JM, Burks J, Contiguglia SR, Rudolph H, Lewin E, Holmes JH: Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs 18: 257, 1972
Plum F, Posner JB: The Diagnosis of Stupor and Coma. Third edition, Philadelphia, FA Davis Co, 1980, p 250
Arieff AI, Llach F, Massry SG: Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 55: 121, 1976
Fishman RA: Neurological manifestations of hyponatremia. in Handbook of Clinical Nelarology, Vol 28, edited by Vinken PJ and Bruyn GW, Amsterdam. North Holland Publishing Company, 1976, p 495
Reynolds EH: Neurological aspects of potassium imbalance. in Handbook of Clinical Neurology, Vol 28, edited by Vinken PJ and Bruyn GW, Amsterdam, North Holland Publishing Company, 1976, p 463
Lockman L: Neurological aspects of acid-base metabolism. in Handbook of Clinical Neurology, Vol 28, edited by Vinken PJ and Bruyn GW, Amsterdam, North Holland Publishing Company, 1976, p 507
Tyler HR: Neurological disorders in renal failure. in Handbook of Clinical Neurology, Vol 27, edited by Vinken PI and Bruyn GW, Amsterdam, North Holland Publishing Company, 1976, p 391
Bradbury M: The Concept of a Blood Brain Barrier. New York, John Wiley and Sons, 1979
Davis FA, Schauf CL: Neurological manifestations of calcium imbalance. in Handbook of Clinical Neurology, Vol 28, edited by Vinken PJ and Bruyn GW, Amsterdam, North Holland Publishing Company, 1976, p 527
Frame B: Neuromuscular manifestations of parathyroid disease. in Handbook of Clinical Neurology, Vol 27, edited by Vinken PJ and Bruyn GW, Amsterdam, North Holland Pubishing Company, 1976, p 283
Rivera-Vazques AB, Noriega-Sánchez A, Ramirez-Gonzalez R, Martinez-Maldonado M: Acute hypercalcemia in hemodialysis patients: distinction from ‘dialysis dementia’. Nephron 25: 243, 1980
Durlach J: Neuromuscular manifestations of magnesium imbalance. in Handbook of Clinical Neurology, Vol 28, edited by Vinken PJ and Bruyn GW, Amsterdam, North Holland Publishing Company, 1976, p 545
Kennedy AC, Linton AL, Luke RG, Renfrew S, Dinwoodi A: The pathogenesis and prevention of cerebral dysfunction during dialysis. Lancet 1:790, 1964
Arieff AI, Massry SG, Barientos A, Kleeman CR: Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 4:177, 1973
Mann H, Stiller S: Elimination of sodium chloride as the cause of dialysis disequilibrium syndrome. (Abstract) Kidney Int 17: 401, 1980
Arieff AI, Guisado R, Massry SG, Lazarowitz VC: Central nervous system pH in uremia and the effect of hemodialysis. J Clin Invest 58: 306, 1976
Arieff AI, Lazarowitz VC, Guisado R: Experimental dialysis disequilibrium syndrome: prevention with glycerol. Kidney Int 14:270, 1978
La Greca G, Biasoli S, Chiaramonte S: Studies of brain density in hemodialysis and peritoneal dialysis. Nephron 21: 146, 1982
Bolton CF, Young GB: Neurological Complications of Renal Disease. Stoneham, MA, Butterworth-Heineman, 1990.
Hughes JR, Schreeder MT: EEG in dialysis encephalopathy. Neurology (NY) 30: 1148, 1980
Dunea G, Mahurkar SD, Mamdani B: Role of aluminum in dialysis dementia. Ann Intern Med 88: 502, 11978
Faris AA: Wernicke’s encephalopathy a compilation of chronic hemodialysis. Arch Neurol 18: 248, 1968
Victor M: The Wernicke Korsakoff syndrome. In Handbook of Clinical Neurology, Vol 28, edited by Vinken PJ and Bruyn GW, Amsterdam, North Holland Publishing Company, 1976, p 243
Dukes MNG: Meyler’s Side Effects of Drugs. Ninth edition, Anmterdam, Excerpla Medica. 1980, p 416
Schwankhaus JD, Massucci EF, Kurtzke JF: Cefazolininduced encephalopathy in a uremic patient. Ann Neurol 17: 211, 1985
Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis and prolonged maintenance hemodialysis. N Engl J Med 290: 679, 1974
Lazarus JM, Lowrie EG, Hampers CL, Merrill JP: Cardiovascular disease in uremic palients on hemodialysis. Kidney Int 7(Suppl 2): S167, 1975
Burke JF Jr, Francos GC, Moore LL, Cho SY. Lasker N: Accelerated atherosclerosis in chronic dialysis: another look. Nephron 21:181, 1978
Rostand SG, Greter JC, Kirk KA, Rutsky EA, Andreoli TE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16: 600, 1979
Lundin AP, Friedman EA: Vascular consequences of maintenance hemodialysis. An unproven case, Nephron 21: 177, 1978
Dinsdale HB: Hypertension and the central nervous system. in Current Neurology, edited by Tyler HR, Dawson DM, Boston, Houghton Mifflin Publ, 1978, p 196
Dinsdale HB: Hypertensive encephalopathy. in Stroke, Pathophysiology, Diagnosis and Management, edited by Barnett HJM, Stein BM, Mohr JP, Yatsu FM, New York, Churchill Livingstone, 1986, p 896
Chester EM, Agamanolis DP, Banker BQ, Victor M: Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology 28: 928, 1978
Nag S, Robertson DM, Dinsdale HB: Cerebral cortical changes in acute experimental hypertension. An ultrastructural study. Lab Invest 36: 150. 1977
Rosenberg G, Kornfeld M, Stovring J, Bicknell JM: Subcortical arteriosclerotic encephalopathy (Bingswanger): computerized tomography. Neurology 29: 1102, 1979
Junck L, Herrick MK, Langston JW: CT-scan in subcortical arteriosclerotic encephalopathy. Neurology 30: 791. 1980
Olzewski J: Subcortical arteriosclerotic encephalopathy. World Neurology 3: 359, 1962
Biemond A: On Binswanger’s subcortical arteriosclerotie encephalopathy and the possibility of its clinical recognition. Psychiatr Neurol Neurosurg 73: 413, 1970
Caplan LR, Schoene WC: Clinical features of subcortical arteriosclerotic encephalopathy. Neurology 28: 1206, 1978
72. Editorial (anonymous): Binswanger’s encephalopathy. Lancet 1:923, 1981
Nichols FT III, Mohr JP: Binswanger’s subacute arteriosclerolic encephalopathy. in Stroke, Pathophysiology, Diagnosis and Management, edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM, New York, Churchill Livingstone, 1986, p 875
De Reuck J, Crevits L, De Coster W, Sieben G, van der Eecken H: Pathogenesis of Binswanger chronic progressive subconical encephalopathy. Neurology 30: 920, 1980
Reinmuth OM: Transient ischemic attacks. in Current Neurology, Vol 1, edited by Tyler HR, Dawson DM, Boston, Houghton Mifflin Publ, 1978, p 166
Mohr JP, Pessin MS: Extracranial carotid artery disease. in Stroke, Pathophysiology, Diagnosis and Management, edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM, New York, Churchill Livingstone, 1986, p 293
Toole JF, Yuson CP: Transient ischemic attacks with normal arteriograms. Serious or benign prognosis. Ann Neurol 1: 100, 1977
Pessin MS, Duncan GW, Mohr JP, Poskanzer DC: Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med 296: 358, 1977
Russo LS: Carotid system transient ischemic attacles: clinical, racial and angiographic correlations. Stroke 12: 470, 1982
Barnett HJM: Antithrombotic therapy in cerebral vascular disease; antispasmodics and fibrinolysins. in Stroke, Pathohysiology, Diagnosis and Management, edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM, New York, Churchill Livingstone, 1986, p 989
Gates PC, Barnett HJM, Silver MD: Cardiogenic stroke. in Stroke, Pathophysiology, Diagnosis and Management, edited by Barnett HJM, Mohr JP, Stein BM, Yatsu FM, New York, Churchill Livingstone, 1986, p 1085
Caplan LR: Intracranial hemorrhage. in Current Neurology, edited by Tyler HR, Dawson DM, Boston, Houghton Mifflin Publ, 1979, p 85
Little JR, Tubman DE, Ethier R: Cerebellar hemorrhage in adults: diagnosis by computerized tomography. J Neurosurg 48: 575, 1978
Crowell RM, Ojemann RG: Spontaneous brain hemorrhage, surgical considerations. in Stroke, Pathophysiology, Diagnosis and Management, edited by Barnett HJM, Mohr SP, Stein BM, Yatsu FM, New York, Churchill Livingstone, 1986, p 1191
Snyder M, Renaudin J: Intracranial hemorrhage associated with anticoagulation therapy. Surg Neurol 7: 31, 1977
Bechar M, Lakke JPW, Van der Hem GK, Beks JWF, Penning L: Subdural hematoma during long term hemodialysis. Arch Neurol 26: 513, 1972
Leonard A, Shapiro FL: Subdural hematoma in regularly hemodialyzed patients. Ann Intern Med 82: 650, 1975
Keane WF, Shapiro FL, Ray L: Incidence and type of infections occurring in 445 hemodialysis patients. Trans Am Soc Artif Intern Organs 23: 41, 1977
Nsouli KA, Lazarus JM, Schoenbaum SC, Gottlieb MN, Lowrie EG, Shocair M: Bacteremic infection in hemodialysis. Arch Intern Med 139: 1255, 1979
Reidenberg MM: The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentration of drugs in patients with poor renal function. Am J Med 62: 466, 1977
Depner T, Gulyassy PF, Stanfel DA, Jarrard EA: Plasma protein binding in uremia: extraction and characterization of an inhibitor. Kidney Int 18: 86, 1980
Reynolds F, Jones NF, Zikoyanis PN, Smith SE: Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet 2: 384, 1976
Bruni J, Wang LH, Marbury TC, Lee CS, Wilder BJ: Protein binding of valproic acid in uremic patients. Neurology 30: 557, 1980
McGonigle RJS, Bewick M, Weston MJ, Parsons V: Progressive predominantly motor uraemic neuropathy. Acta Neurol Scand 71: 379, 1985
Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ: Polyneuropathy in critically ill patients. J Neurol Neurosur Psychiatry 47: 1223, 1984
Asbury AK: Neuropathies with renal failure, hepatic disorders, chronic respiratory insufficiency and critical illness. in Peripheral Neuropathy, edited by Dyck PJ, Thomas PK et al., Philadelphia, WB Saunders, 1993, p 1251
Said G, Boudier L, Selva J, Zingraff J, Drüecke T: Different patterns of uremic polyneuropathy: clinicopathologic study. Neurology 33: 567, 1983
Mulder DW: Motor neuron disease. in Peripheral Neuropathy, edited by Dyck PJ, Thomas PK, Lambert EH, Philadelphia, WB Saunders Co, 1975, p 759
Callaghan N: Restless legs syndrome in uremic neuropathy. Neurology 17: 359, 1966
Boghen D: Successful treatment of restless legs with clonazepatn. Ann Neurol 6: 341, 1979
Jennekens FGI, Dorhout Mees EJ, Van der Most van Spijk D: Uraemic polyneuropathy. Nephron 8: 414, 1971
Nielsen VK: The peripheral nerve function in chronic renal failure. I Clinical symptoms and signs. Acta Med Scand 190: 105, 1971
Nielsen VK: The peripheral nerve function in chronic renal failure. VII Longitudinal course during terminal renal failure and regular dialysis. Acta Med Scand 195: 155, 1974
Nielsen VK: The peripheral nerve function in chronic renal failure. An analysis of the vibratory perception threshold. Acta Med Scand 191: 287, 1972
Hennessy WJ, Siemsen AW: Autonomic neuropathy in chronic renal failure. Clin Res 16: 385, 1968
Kersch ES, Krohnfield SJ, Unger A, Popper RW, Cantor S, Conn K: Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 290: 650, 1974
Röckel A, Henneman H, Sternagel-Haase A, Heidhand A: Uraemic sympathetic neuropathy after haemodialysis and transplantation. Eur J Clin Invest 9: 23, 1979
Zuchelli P, Sturani A, Zuccala A, Santoro A, Degli Esposti E, Chiarini C: Dysfunction of the autonomic nervous system in patients with end-stage renal failure. Contr Nephrol 45: 69, 1985
Solders G, Persson A, Gutierrez A: Autonomic dysfunction in non-diabetic terminal uraemia. Acta Neurol Scand 71: 321, 1985
Mallamaci F, Zoccali C, Cicareili M, Briggs JD: Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol 25: 175, 1986
Solders G: Autonomic function tests in healthy controls and in terminal uraemia. Acta Neurol Scandli: 638, 1986
Mentser MI, Clay S, Malekzadeh MH, Pennisi AJ, Ettenger RB, Uittenbogaart CH, Finc RN: Peripheral motor nerve conduction velocities in children undergoing chronic hemodialysis. Nephron 22: 337, 1978
Chan JC, Eng G: Long-term hemodialysis and nerve conduction in children. Pediat Res 13: 591, 1979
Nielsen VK: The peripheral nerve function in chronic renal failure. V Sensory and motor conduction velocity. Acta Med Scand 194: 445, 1973
Van der Most van Spijk D, Hoogland RA, Dijkstra S: Conduction velocities compared and related to degrees of renal insufficiency. in New Developments in Electromyography and Clinical Neurophysiology, Vol 2, edited by Desmedt JE, Basel, Karger, 1973, p 381
Dinn JJ, Crane DL: Schwann cell dysfunction in uraemia. J Neurol Neurosurg Psychiatry 33: 605, 1970
Bergström J, Lindblom U, Norée LO: Preservation of peripheral nerve function in severe uraemia during treatment with low protein, high calorie diet and surplus of essential amino-acids. Acta Med Scand 51: 99, 1975
Capelli P, Di Paolo B, Evangelista M, Di Marco T, Albertazzi A: Low protein diet supplemented with essential amino acids and keto analogues. Effects on uremic polyneuropathy and encephalopathy. Contr Nephrol 53: 58, 1986
Caccia MR, Mangili A, Mecca G, Ubiali E, Zanoni P: Effects of haemodialytic treatment on uremic polyneuropathy. J Neurol 217: 193, 1977
Cadilhac J, Mion C, Duday H, Dapres G, Georgesco M: Motor nerve conduction velocities as an index of the efficiency of maintenance dialysis in patients with end-stage renal failure. in Peripheral Neuropathies, edited by Canal N, Pozza G, Amsterdam, Elsevier, North Holland Biomedical Press, 1978, p 211
Kurts SB, Wong VH, Anderson CF, Vogel JP, McCarthy JT, Mitchell JC, Kumar R, Johnson WJ: Continuous ambulatory peritoneal dialysis. Three years’ experience at the Mayo Clinic. Mayo Clin Proc 58: 633, 1983
Tegnér R, Lindholm B: Uremic polyneuropathy: different effects of hemodialysis and continuous ambulatory peritoneal dialysis. Acta Med Scand 218: 409, 1985
Stanley E, Brown JC, Pryor JS: Altered peripheral nerve function resulting from haemodialysis. J Neurol Neurosurg Psychiatry 40: 39, 1977
Edwards AE, Kopple JD, Kornfeld CM: Vibrotactile threshold in patients undergoing maintenance dialysis. Arch Intern Med 132: 706, 1973
Castaigne P, Cathala HP, Beaussart-Boulengé L, Petrover M: Effect of ischaemia on peripheral nerve function in patients with chronic renal failure undergoing dialysis treatment. J Neurol Neurosurg Psychiatry 35: 631, 1972
Lowitzsch K, Göhring U, Hecking E, Köhler H: Refractory period, sensory conduction velocity and visual evoked potentials before and after haemodialysis. J Neurol Neurosurg Psychiatry 44: 121, 1981
Dyck PJ, Johnson WJ, Lambert EH, O’Brien PC, Daube JR, Ovratt KF: Comparison of symptoms, chemistry and nerve function to assess adequacy of hemodialysis. Neurology 9: 1361, 1979
Nielsen VK: The peripheral nerve function in chronic renal failure, A survey. Acta Med Scand 573Suppl) 8 1975
Ibraham MM, Crosland JM, Honigsberger L, Bmes AD, Dawson-Edwards P, Newman CE, Robinson BHB: Effect of renal transplantation on uraemic neuropathy. Lancet 2: 739, 1974
Nielsen VK: The peripheral nerve function in chronic renal failure. IX Recovery after transplantation. Electrophysiological aspects (sensory and motor nerve conduction). Acta Med Scand 195: 171, 1974
Oh SJ, Clements RS, Lee YW, Diethelm AG: Rapid improvement in nerve conduction velocity following renal transplantation. Ann Neurol 4: 369, 1978
Nielsen VK: The peripheral nerve function in chronic renal failure. VII Recovery after renal transplantation. Clinical aspects. Acta Med Scand 195: 163, 1974
Bolton CF: Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology 26: 152, 1976
Asbury AK, Victor M, Adams RD: Uremic polyneuropathy. Arch Neurol 8: 413, 1963
Forno L, Alston W: Uremic polyneuropathy. Acta Neurol Scand 43:640, 1967
Jennekens FGI, Dorhout Mees EJ, van der Most van Spijk D: Nerve fibre degeneration in uraemic polyneuropathy. Proc Eur Dial Transplant Assoc 6: 191, 1969
Thomas PK, Hollinrake K, Lascelles RG, O’Sullivan DJ, Baillod RA, Moorhead JF, Mackenzie JC: The polyneuropathy of chronic renal failure. Brain 94: 761, 1971
Dayan AD, Gardner-Thorpe C, Down PF, Gleadle RI: Peripheral neuropathy in uremia. Neurology 20: 649, 1970
Dyck PJ, Johnson WJ, Lambert EH, O’Brien PC: Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 46: 400, 1971
Hansen S, Ballantyne JP: A quantitative electrophysiological study of uraemic neuropathy. J Neurol Neurosurg Psychiatry 41: 128, 1978
Said G, Goulon-Goeau C, Slama G, Tchobroutsky G: Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. N Engl J Med 326: 1257, 1992
Pekelharing CA, Winkler C: Mitteilung über die Beriberi (Communication on beriberi). Dtsch Med Wochenschr 13: 845, 1887 (in German)
Babb AL, Popovich RP, Christopher TG, Scribner BH: The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs 17: 81, 1971
Tenckhoff H, Shilipetar G, Boen ST: One year’s experience with home peritoneal dialysis. Trans Am Soc Artif Intern Organs 11: 11, 1968
Raskin NH, Fishman RA: Neurological disorders in renal failure (Second of two parts). N Engl J Med 294: 204, 1976
Merrill JP: The search for ‘factor X’. Clin Nephrol 11: 56, 1979
Baker LRI, Marshall RD: A reinvestigation of methylguanidine concentration in sera from normal and uraemic subjects. Clin Sci 41: 563, 1971
Blumberg A, Esslen E, Bürgi W: Myoinositol — a uremic neurotoxin. Nephron 21: 186, 1971
Sterzel RB, Semar M, Lonergan ET, Treser G, Lange K: Relationship of nervous tissue transketolase to the neuropathy in chronic uremia. J Clin Invest 50: 2295, 1971
Kopple JD, Dirige OV, Jacob M, Wang M, Swenseid ME: Transketolase activity in red blood cells in chronic uremia. Trans Am Soc Artif Intern Organs 18: 250, 1972
Dobbelstein H, Körner WF, Mempel W, Grosse-Wilde H, Edel HH: Vitamin B6 deficiency in uremia and its implication for the depression of immune responses. Kidney Int 5: 233, 1974
Nielsen VK: Pathophysiological aspects of uraemic neuropathy. in Peripheral Neuropathies, edited by Canal N, Pozza G, Amsterdam, Elsevier/North Holland Biomedical Press, 1978, p 197
Brismar T, Tegnér R: Experimental uremic neuropathy. Part 2 (Sodium permeability decrease and inactivation in potential clamped nerve fibres). J Neurol Sci 65: 37, 1984
Goldstein DA, Chui LA, Massry SG: Effects of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J Clin Invest 62: 88, 1978
Avram MM, Iancu M, Morrow P, Feinfeld D, Huatuco A: Uremic syndrome in man: new evidence for parathormone as a multisystem neurotoxin. Clin Nephrol 11: 59, 1979
Schaefer K, Offerman G, Von Herrath D, Schröter R, Stolzer R, Arntz HR: Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients. Clin Nephrol 14: 81, 1980
Driieke T, Chkoff N, DiGiulo S, Zingraff J, Delons S, Man NK, Jungers P, Crosnier J: Absence of increased motor nerve conduction velocity after parathyroidectomy in dialysis patients. (Abstract) Kidney Int 15: 449, 1979
Layzer RB: Neuromuscular Manifestations of Systemic Disease, Philadelphia, FA Davis Co, 1985, p 112
Pagani, C, Zoerle, C, Guaita MC, Bazzi C, Sovgato G, Torgi G: Carpal tunnel syndrome in long-term dialyzed patients. Contr Nephrol 45: 72, 1985
Warren DJ, Otieno LS: Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgrad Med J 51: 450, 1975
Bosanac PR, Bilder B, Grunberg RW, Banach SF, Kintzel JE, Stephens HW: Post-permanent access neuropathy. Trans Am Soc Artif Intern Organs 23: 162, 1977
Harding AE, LeFanu J: Carpal tunnel syndrome related to antebrachial Cimino-Brescia fistula. J Neurol Neurosurg Psychiatry 40: 511, 1977
Walts AE, Goodman MD, Matoru PA: Amyloid carpal tunnel syndrome and chronic hemodialysis. Am J Nephrol 5: 225, 1985
Chanard J, Lavaud S, Toupance O, Melin JP, Gillery P, Revillard JP: B2 microglobulin-associated amyloidosis in chronic haemodialysis patients. Lancet 1: 1212, 1986
Ballardie FW, Kerr DNS, Tennent G, Pepys MB: Haemodialysis versus CAPD: equal predisposition to amyloidosis. Lancet 1: 795, 1986
Hamilton DV, Evans DB, Henderson RG: Ulnar nerve lesion as complication of Cimino-Brescia arteriovenous fistula. Lancet 2: 1137, 1980
Ahmad R, Raichura N: Ulnar nerve lesion as complication of Cimino-Brescia arteriovenous fistula. Lancet 2: 1381, 1980
Bailey RR, Lynn KL: Arteriovenous shunts and nerve damage. Lancet 1: 211, 1981
Bolton CF, Driedger AA, Lindsay RM: Ischaemic neuropathy in uraemic patients caused by bovine arteriovenous shunt. J Neurol Neurosurg Psychiatry 42: 810, 1979
Ahonen RE: Light microscopic study of striated muscle in uremia. Acta Neuropathol (Berl) 49: 51, 1980
Kopple JD: Abnormal amino acid and protein metabolism in uremia. Kidney Int 14: 340, 1983
Alvestrand A, Fürst P, Bergström J: Intracellular amino acids in uremia. Kidney Int 24(Suppl 16): 9, 1983
Jennekens FGI: Disuse, cachexia and ageing. in Skeletal Muscle Pathology, edited by Mastaglia FL, Walton JN, Edinburgh, London, New York, Churchill-Livingstone, 1981, p 605
DelCanale S, Fiaccadori E, Ronda N, Söderlund K, Antonucci C, Guariglia A: Muscle energy metabolism in uremia. Metabolism 35: 981, 1986
Bethlem J: Myopathies, Second edition, Amsterdam, Elsevier North Holland, 1980, p 269
Böhmer T, Bergrem H, Eiklid K: Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1: 126, 1978
Mingardi G, Bizzi A, Cini M, Licini R, Mecca G, Garatini S: Carnitine balance in hemodialyzed patients. Clin Nephrol 13: 269, 1980
Bizzi A, Cini M, Garattini S, Mingardi G, Licini R, Mecca G: L-carnitine addition to haemodialysis liquid prevents plasma carnitine deficiency during dialysis. Lancet 1: 882, 1979
DiMauro S, Trevissan C, Hays A: Disorders of lipid metabolism in muscle. Muscle Nerve 3: 369, 1980
Lacour B, Chanard J, Haguet M, Basile D, Assan R, Di Giulio S, Ciancioni C, Lebkiri B, Drüeke T, Funck Brentano JL: Carnitine improves lipid abnormalities in haemodialysis patients. Lancet 2: 763, 1980
Bazzato G, Coli U, Landini S, Mezzina C, Ciman M: Myasthenia-like syndrome after D,Lbut not L-carnitine. Lancet 1: 1209, 1981
Clair F, Caillat S, Soufir JC, Lafforgue B, Drüeke T, Said G: Syndrome myasthénique induit par la D,L carnitine chez un hémodialysé chronique. Press Méd 13: 1154, 1984
West TPJ: A comparison of predialysis and postdialysis cognitive abilities. Dial Transplant 7: 809, 1978
Hagberg B: A prospective study of patients in chronic hemodialysis III. Predictive value of intelligence, cognitive deficit and ego defense structures in rehabilitation. J Psychosom Res 18: 151, 1974
Teschan PE, Ginn HE, Bourne JR, Ward JW: Neurobehavioral probes for adequacy of dialysis. Trans Am Soc Artif Intern Organs 23: 556, 1977
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Said, G. (1996). Neurological Aspects of Dialysis Patients. In: Jacobs, C., Kjellstrand, C.M., Koch, K.M., Winchester, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-36947-1_52
Download citation
DOI: https://doi.org/10.1007/978-0-585-36947-1_52
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-3610-5
Online ISBN: 978-0-585-36947-1
eBook Packages: Springer Book Archive